Catalysts for Mylan Institutional Inc

Rifampin Injection shortage — Mylan Institutional, a Viatris Company

Rocuronium Bromide Injection shortage — Mylan Institutional, a Viatris Company

Remifentanil Hydrochloride Injection shortage — Mylan Institutional, a Viatris Company

Dexmedetomidine Hydrochloride Injection shortage — Mylan Institutional, a Viatris Company

Dexamethasone Sodium Phosphate Injection shortage — Mylan Institutional, a Viatris Company

Etomidate Injection shortage — Mylan Institutional, a Viatris Company

ISOSULFAN BLUE — FDA approval

METHADONE HYDROCHLORIDE — FDA approval

ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval

ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval

Safecor Health, LLC recall (Cls II)

Mylan Institutional, Inc. recall (Cls II)

Mylan Institutional, Inc. recall (Cls II)

Mylan Institutional, Inc. recall (Cls II)

Mylan Institutional, Inc. recall (Cls II)

Mylan Institutional, Inc. recall (Cls II)

Mylan Institutional, Inc. recall (Cls II)

Mylan Institutional, Inc. recall (Cls II)

Mylan Institutional, Inc. recall (Cls II)

METHADONE HYDROCHLORIDE — FDA approval

ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval

METHADONE HYDROCHLORIDE — FDA approval

METHADONE HYDROCHLORIDE — FDA approval

METHADONE HYDROCHLORIDE — FDA approval

ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval

ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval

METHADONE HYDROCHLORIDE — FDA approval

ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval

ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval

METHADONE HYDROCHLORIDE — FDA approval